Literature DB >> 10797447

The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant?

M Exner1, R Thalhammer, S Kapiotis, G Mitterbauer, P Knöbl, O A Haas, U Jäger, I Schwarzinger.   

Abstract

The immunophenotypes of 12 acute promyelocytic leukemias (APL-M3; eight hypergranular, four microgranular) with documented PML-RAR-alpha fusion gene are presented. Bone marrow mononuclear cells were immunophenotyped using a panel of 20 monoclonal antibodies. The hypergranular APLs exhibited a mature myeloid phenotype as it has been described to be typical for M3. No lineage infidelity was detectable in classic M3 cases. In contrast, among the four cases of M3 variant, all leukemias showed marked expression of CD34 and two of four cases expressed the HLA-DR antigen. The CD2 antigen was expressed in three of four cases. Furthermore, one case showed expression of the CD56 antigen, and one case was positive for the blood group H antigen. The data suggest that microgranular APL is a heterogeneous entity with regard to the immunologic phenotype. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797447

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  5 in total

1.  Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry.

Authors:  Zhanguo Chen; Yan Li; Yongqing Tong; Qingping Gao; Xiaolu Mao; Wenjing Zhang; Zunen Xia; Chaohong Fu
Journal:  Int J Hematol       Date:  2016-01-12       Impact factor: 2.490

2.  Diagnostic immunophenotype of acute promyelocytic leukemia before and early during therapy with all-trans retinoic acid.

Authors:  Pedro Horna; Ling Zhang; Eduardo M Sotomayor; Jeffrey E Lancet; Lynn C Moscinski
Journal:  Am J Clin Pathol       Date:  2014-10       Impact factor: 2.493

3.  Clinical and pathologic features of secondary acute promyelocytic leukemia.

Authors:  Amy S Duffield; Joseph Aoki; Mark Levis; Kathleen Cowan; Christopher D Gocke; Kathleen H Burns; Michael J Borowitz; Milena Vuica-Ross
Journal:  Am J Clin Pathol       Date:  2012-03       Impact factor: 2.493

4.  The biological characteristics of adult CD34+ acute promyelocytic leukemia.

Authors:  Ebtesam Ibrahim Ahmad; Hosneia Kh Akl; Mona E Hashem; Tarek Ali M Elgohary
Journal:  Med Oncol       Date:  2011-03-12       Impact factor: 3.064

5.  Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patients.

Authors:  Nikolay D Dimov; L Jeffrey Medeiros; Hagop M Kantarjian; Jorge E Cortes; Kun-Sang Chang; Carlos E Bueso-Ramos; Farhad Ravandi
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.